Mortality following ACS is influenced by the patients' baseline characteristics, the severity of the initial and recurrent event(s), and the extent of coronary artery disease and left ventricular dysfunction (18,127-130). Following any of the ACS, patients remain at risk for recurrent events with approx 15-25% of patients developing recurrent ischemia or infarction by 1 yr (131,132). If such recurrent events occur, subsequent mortality is higher (133,134). Thus, early identification and treatment of the patient to prevent recurrent ischemic complications is important and is described in detail in this book.
Was this article helpful?